Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDDDD.L Regulatory News (DDDD)

  • There is currently no data for DDDD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Suspension - 4D Pharma PLC

24 Jun 2022 12:30

RNS Number : 1476Q
AIM
24 June 2022
 

NOTICE

 

24/06/2022 12:30pm

 

TEMPORARY SUSPENSION OF TRADING ON AIM

 

4D PHARMA PLC

 

At the request of the Company trading on AIM for the under-mentioned securities has been temporarily suspended from 24/06/2022 12:30pm, pending an announcement.

 

ORDINARY SHARES OF 0.25P EACH, FULLY PAID (BJL5BR0) (GB00BJL5BR07)

 

If you have any queries relating to the above, please contact the company's nominated adviser on +44 (0)20 7496 3000.

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
EXCEAFKLAFSAEFA
Date   Source Headline
21st Dec 20187:00 amRNSDirector/PDMR Shareholding
19th Dec 20187:00 amRNSDirector/PDMR Shareholding
13th Dec 20187:00 amRNSPDMR Dealings
12th Dec 20184:40 pmRNSSecond Price Monitoring Extn
12th Dec 20184:35 pmRNSPrice Monitoring Extension
12th Dec 20187:00 amRNSTrading Statement
8th Nov 20187:00 amRNSClinical Update - Blautix Phase II study
8th Nov 20187:00 amGNW4D pharma plc Announces Clinical Update for Blautix Phase II Study
28th Sep 20187:00 amRNSInterim results
24th Sep 20187:00 amRNSClinical update and publication of studies
14th Aug 20187:00 amRNS4D asthma publication
30th Jul 20187:00 amRNSPublication - microbiota as HDAC inhibitors
27th Jun 20187:00 amRNS4D Presents at IHMC 2018
25th Jun 20184:40 pmRNSSecond Price Monitoring Extn
25th Jun 20184:35 pmRNSPrice Monitoring Extension
13th Jun 20187:00 amRNSMHRA and HPRA clear Blautix Phase II study
12th Jun 20184:51 pmRNSHolding(s) in Company
7th Jun 20187:00 amRNSClinical Collaboration Agreement
4th Jun 20187:00 amRNS4D Presents Phase Ib Clinical Data on Blautix
21st May 201812:08 pmRNSResult of AGM
21st May 20187:00 amRNSMRx0518 - Monotherapy trial approved
8th May 20187:00 amRNSClinical Update - Blautix IND
26th Apr 20187:00 amRNSAnnual Report and Notice of AGM
23rd Apr 20187:00 amRNSFinal Results
21st Mar 20187:00 amRNSOncology candidate update
20th Feb 20187:00 amRNSAppointment of Joint Broker
28th Sep 20177:00 amRNSInterim results
5th Sep 201712:54 pmRNSHolding(s) in Company
24th Aug 20177:00 amRNSIssue of Equity
26th May 20171:59 pmRNSResult of AGM
17th May 20174:40 pmRNSSecond Price Monitoring Extn
17th May 20174:35 pmRNSPrice Monitoring Extension
3rd May 20177:00 amRNSAnnual Report and Notice of AGM
27th Apr 20177:00 amRNSFinal Results
18th Apr 20177:59 amRNSAppointment of Joint Broker
10th Mar 20174:37 pmRNSHolding(s) in Company
6th Mar 20177:00 amRNSClinical Update
13th Dec 20167:00 amRNSClinical Update
9th Nov 20164:40 pmRNSSecond Price Monitoring Extn
9th Nov 20164:35 pmRNSPrice Monitoring Extension
8th Nov 20164:40 pmRNSSecond Price Monitoring Extn
8th Nov 20164:35 pmRNSPrice Monitoring Extension
19th Oct 20164:40 pmRNSSecond Price Monitoring Extn
19th Oct 20164:35 pmRNSPrice Monitoring Extension
30th Sep 20167:00 amRNSInterim results for the period ended 30 June 2016
27th Sep 201610:59 amRNSHolding(s) in Company
15th Sep 20164:40 pmRNSSecond Price Monitoring Extn
15th Sep 20164:35 pmRNSPrice Monitoring Extension
9th Sep 201611:58 amRNSHolding(s) in Company
22nd Aug 20167:00 amRNSClinical Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.